14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.38 $110.93 Friday, 3rd May 2024 BPMC stock ended at $107.19. This is 0.178% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.50% from a day low at $106.15 to a day high of $110.93.
90 days $72.25 $110.93
52 weeks $43.89 $110.93

Historical Blueprint Medicines Corporation prices

Date Open High Low Close Volume
Jul 24, 2020 $75.37 $75.97 $73.53 $74.67 377 192
Jul 23, 2020 $77.69 $79.23 $75.15 $76.01 377 034
Jul 22, 2020 $77.02 $79.02 $76.87 $78.45 301 600
Jul 21, 2020 $79.17 $79.19 $76.79 $77.44 465 600
Jul 20, 2020 $78.36 $79.26 $76.57 $78.43 576 000
Jul 17, 2020 $77.50 $78.88 $76.47 $77.67 890 300
Jul 16, 2020 $79.31 $80.00 $76.71 $77.53 946 200
Jul 15, 2020 $81.52 $82.33 $79.55 $80.10 1 000 600
Jul 14, 2020 $80.00 $81.00 $74.58 $79.97 2 455 500
Jul 13, 2020 $79.50 $80.06 $76.47 $76.65 429 800
Jul 10, 2020 $78.70 $79.84 $78.05 $78.97 219 300
Jul 09, 2020 $78.44 $79.33 $76.68 $78.38 263 800
Jul 08, 2020 $77.14 $78.81 $76.83 $78.66 458 000
Jul 07, 2020 $78.61 $79.86 $77.19 $77.19 436 200
Jul 06, 2020 $80.02 $81.07 $78.82 $79.32 376 500
Jul 02, 2020 $80.11 $80.92 $78.51 $79.15 265 494
Jul 01, 2020 $77.84 $80.64 $77.25 $79.02 598 307
Jun 30, 2020 $76.51 $78.66 $75.80 $78.00 464 108
Jun 29, 2020 $76.21 $78.25 $74.84 $76.55 329 754
Jun 26, 2020 $78.55 $78.55 $75.10 $75.59 703 749
Jun 25, 2020 $76.08 $79.19 $75.22 $79.17 406 955
Jun 24, 2020 $78.01 $78.94 $75.46 $76.24 292 546
Jun 23, 2020 $79.56 $80.25 $78.22 $78.94 553 942
Jun 22, 2020 $78.80 $80.98 $77.36 $79.27 401 220
Jun 19, 2020 $76.57 $79.15 $76.18 $78.80 1 070 333
Click to get the best stock tips daily for free!

About Blueprint Medicines Corporation

Blueprint Medicines Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally avail... BPMC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT